The outcomes showed lycopene's potential in mitigating NAFLD by regulating SIRT1/AMPK and NAMPT and by reducing NF‐kB, IL‐6, IL‐1β, and TNF‐α activation. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.